A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
Titel:
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
Auteur:
Wagner, A.J. Kindler, H. Gelderblom, H. Schöffski, P. Bauer, S. Hohenberger, P. Kopp, H.-G. Lopez-Martin, J.A. Peeters, M. Reichardt, P. Qin, A. Nippgen, J. Ilaria, R.L. Rutkowski, P.